Castillo-Quan JI, Kinghorn KJ

Language: Spanish
References: 30
Page: 680-685
PDF size: 215.72 Kb.

ABSTRACT

For many years aging research was confined to statistics, psychology, and socioeconomic aspects of old age. However, today the study of aging is one of the most attractive and prosperous fields in biology. This change followed on from observations that single gene mutations can modulate the aging process, demonstrating the dynamic and plastic nature of the pathways involved. The field of aging is continually being fuelled by the discovery of new genes and pathways that extend lifespan when manipulated in organisms ranging from unicellular yeast to the more complex round worm C. elegans and the fruit fly Drosophila melanogaster. Such interventions have also been successful in mammals, proving the principle that discoveries in invertebrates can be evolutionarily relevant to humans.
The most successful and evolutionary conserved interventions are those related to nutrient sensing pathways, the effector pathways upon which dietary restriction operates to promote health and longevity. To validate the existence of genes that modify the aging process in humans, biogerontologists have opted for a genome-wide approach to studying centenarians, those fortunate to live beyond 100 years of age. By studying these individuals, they hope to unravel the genetic signatures that promote healthy ageing and long life.

REFERENCES

1. Bloom DE. 7 Billion and Counting. Science. 2011;333(6042):562-9.

2. Góngora-Alfaro JL. La cafeína como un fármaco preventivo de la enfermedad de Parkinson: evidencias epidemiológicas y sustrato experimental. Rev Neurol. 2010;50(4):221-9.

3. Castillo-Quan JI, Perez-Osorio JM. Alzheimer’s disease and methylenetetrahydrofolate reductase gene polymorphisms: a potential nutrigenomic approach for Mexico. Gac Med Mex. 2009;146(2):147-50.

4. Castillo-Quan JI. Parkin’ control: regulation of PGC-1α through PARIS in Parkinson’s disease. Dis Model Mech. 2011;4(4):427-9.

5. Bourzac K. Live long and prosper? Nature. 2012;492:S18-20.

6. Gems D, Partridge L. Genetics of longevity in model organisms: debates and paradigm shifts. Annu Rev Physiol. 2013;75:621-44.

7. Doonan R, McElwee JJ, Matthijssens F, et al. Against the oxidative damage theory of aging: superoxide dismutases protect against oxidative stress but have little or no effect on life span in Caenorhabditis elegans. Genes Dev. 2008;22(23):3236-41.

8. Gems D, De la Guardia Y. Alternative Perspectives on Aging in Caenorhabditis elegans: Reactive Oxygen Species or Hyperfunction? Antioxid Redox Signal. 2013;19(3):321-9.

9. Fontana L, Partridge L, Longo VD. Extending healthy life span--from yeast to humans. Science. 2010;328(5976):321-6.

10. Kenyon C. The first long-lived mutants: discovery of the insulin/IGF-1 pathway for ageing. Philos Trans R Soc Lond B Biol Sci. 2011; 366(1561):9-16.

11. Clancy DJ, Gems D, Harshman LG, et al. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science. 2001;292(5514):104-6.

12. Selman C, Lingard S, Choudhury AI, et al. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J. 2008;22(3):807-18.

13. Blüher M, Kahn BB, Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science. 2003;299(5606):572-4.

14. Bartke A, Sun LY, Longo V. Somatotropic signaling: trade-offs between growth, reproductive development, and longevity. Physiol Rev. 2013;93(2):571-98.

15. Partridge L, Alic N, Bjedov I, Piper MDW. Ageing in Drosophila: the role of the insulin/Igf and TOR signalling network. Exp Gerontol. 2011;46(5): 376-81.

16. Bartke A, Westbrook R. Metabolic characteristics of long-lived mice. Front Genet. 2012;3:288.

17. Slack C, Giannakou ME, Foley A, Goss M, Partridge L. dFOXO-independent effects of reduced insulin-like signaling in Drosophila. Aging Cell. 2011;10:735-48.

18. Giannakou ME, Goss M, Jünger MA, Hafen E, Leevers SJ, Partridge L. Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science. 2004;305(5682):361.

19. Bjedov I, Partridge L. A longer and healthier life with TOR downregulation: genetics and drugs. Biochemic Soc Trans. 2011;39(2): 460-5.

20. Lamming DW, Ye L, Katajisto P, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science. 2012;335(6076):1638-43.

21. Simonsen A, Cumming RC, Brech A, Isakson P, Schubert DR, Finley KD. Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila. Autophagy. 2008;4(2):176-84.

22. Hansen M, Chandra A, Mitic LL, Onken B, Driscoll M, Kenyon C. A role for autophagy in the extension of lifespan by dietary restriction in C. elegans. PLoS Genet. 2008;4(2):e24.

23. Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460 (7253):392-5.

24. Bjedov I, Toivonen JM, Kerr F, et al. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab. 2010; 11(1):35-46.

25. Lombard DB, Pletcher SD, Canto C, Auwerx J. Longevity hits a roadblock. Nature. 2011;477:410-1.

26. Burnett C, Valentini S, Cabreiro F, et al. Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature. 2011; 477(7365):482-5.

27. Bernardes de Jesus B, Vera E, Schneeberger K, et al. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol Med. 2012;4(8):691-704.

28. Liu N, Landreh M, Cao K, et al. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature. 2012;482(7386): 519-23.

29. Barzilai N, Guarente L, Kirkwood TBL, Partridge L, Rando TA, Slagboom PE. The place of genetics in ageing research. Nat Rev Genet. 2012;13(8):589-94.

30. Eisenstein M. Great expectations. Nature. 2012;492:S6-8.